We have compared the phenotype of genotyped populations to clarify whether or not each of these two genotypes has a distinctive phenotype.
confirmed that more than 98% of patients with ACH have an identical glycine-to-arginine substitution at residue 380 (G380R) of fibroblast growth factor receptor 3 (FGFR3)3-6. This exceptional genotypic homogeneity is likely to contribute to the phenotypic homogeneity of ACH. Hypochondroplasia (HCH) is another disorder with short-limbed short stature and autosomal dominant inheritance. Many of its features resemble those of ACH, but the abnormalities are less severe overall and the face is almost completely normal. About 60% of patients with HCH have been reported to have an asparagine-to-lysine substitution at residue 540 (N540K) of FGFR3.10,11 Although the genotypic background of the remaining cases of HCH has not been clarified, the N540K substitution seems to be responsible for a significant proportion of cases of this condition.12-14 In spite of a long history of 50 observations suggesting allelism between ACH and HCH15, it has been claimed that the clinical and radiological features of ACH and HCH overlap. 16, 17 We have compared the phenotype of genotyped populations to clarify whether or not each of these two genotypes has a distinctive phenotype.
Patients and Methods
Blood samples were collected from patients clinically diagnosed as having ACH and HCH, and the FGFR3 genotype was determined as previously described.
There were 23 patients with ACH and the G380R substitution, 11 boys and 12 girls with a mean age of 10.0 years (5 to 18). Of the eight HCH patients with the N540K substitution, there were five boys and three girls with a mean age of 11.6 years (7 to 18), all of whom had sporadic mutations. We also assessed 30 genetically normal individuals as a control group.
There were 17 boys and 13 girls with a mean age of , 
Results
Both groups of patients had severe short stature. The mean height standard deviation score of the G380R patients was -5.3 ± 1.2 which was lower than that of the N540K patients (-4.2 ± 1.5) although there was no statistical significance (p = 0.0502;). The mean span to height ratio percentage of the G380R patients was 90.4 ± 3.6 which was significantly lower than that of the N540K patients (96.9 ± 2.4; p < 0.0001;f).
The lumbar interpedicular distance was considerably reduced in both groups in comparison with the normal controls. 23 In the G380R patients the mean L1/ L4 ratio was l.18 ± 0.10 which was significantly higher than that of the N540K patients (1.02 ± 0.09; p = 0.0006;), but the latter was itself significantly higher than that of the normal group (0.89 ± 0.05; p = 0.0032). The mean F/T ratio in the G380R patients was 1.12 ± 0.03 which was significantly higher than that of the N540K patients (1.07 ± 0.03; p = 0.0002), but again the latter was significantly higher than that of the control group ( 1.01 ± 0.02; p = 0.0002;). The mean pelvic index of the G380R patients was 0.42 ± 0.03 which was significantly higher than that of the N540K patients (0.37 ± 0.04; p = 0.0026;). There was no significant difference in the pelvic index between the N540K patients and the control group (0.37 ± 0.03; p = 0.8908).
Discussion
We have shown that patients with ACH (G380R genotype) and HCH (N540K genotype) shared the classical skeletal changes (i.e., phenotype) to different degrees. According to the height standard deviation score and the span to height ratio percentage, the micromelic short stature was present in both conditions, but was more severe in ACH. Measurement of the L1/L4 ratio, the F/T ratio, and the pelvic index showed that the reduction of the interpedicular distances in the lower lumbar spine, the disproportionally long fibulae, and the squared iliac bones were more pronounced in ACH than in HCH. Both conditions carry a distinct mutation of FGFR3, which is a negative regulator of bone growth. 24 
